the National Key Research and Development Program of China(2021YFC400600,2022YFE0203600);the National Natural Science Foundation of China(81925035 and 82341232);the Future Network(083GJHZ2023012FN);Grand Challenges(083GJHZ2023021GC)of the International Partnership Program of the Chinese Academyof Sciences,CAS President’s International Fellowship Initiative(2024VBB0004);High-level Innovative Research Institute(2021B0909050003)from Department of Science;Technology of Guangdong Province;Zhongshan Municipal Bureau of Science and Technology(LJ2021001 and CXTD2022011).
Glycolysis-related lactic acid overproduction creates an“ion-trapping”barrier and immunosuppressive tumor microenvironment that compromise effective intratumoral drug delivery and therapy.Therefore,normalization of ...
supported by the grants from the National Natural Science Foundation of China(Nos.81973251 and 81302725);Hebei Province Funding Project for Introduced Overseas Personnel(Nos.C20230351 and C20220345);Key Research and Development Program of Hebei Province(No.22372701D);Hebei Province Natural Science Fund(No.H2020206610);Hebei Provincial Health Commission Government-Funded Clinical Medicine Talent Program(No.ZF2024048);Hebei Medical University Undergraduate Innovative Experiment Program(No.USIP2023008)。
The combination of nucleic acid and small-molecule drugs in tumor treatment holds significant promise;however,the precise delivery and controlled release of drugs within the cytoplasm encounter substantial obstacles,i...
This work was supported by the Doctoral Start-up Foundation of Liaoning Province of China[Grant Number 2023-BS-086];the Fundemental Research Funds for Public Universitiesin Liaoning(LJKJT202402);the Youth Project of Liaoning Provincial Department of Education(JYTQN2023188);the Youth Scientific Research Fund Project of Liaoning University.
Tumormetastasis is responsible for 90%of cancer-associated deaths,and its early detection may decrease the likelihood of mortality.Studies have demonstrated that metastasis results from the interaction between“seeds...
National Research Programs from the Ministry of Science and Technology of China,Grant/Award Numbers:2021YFF0701800,2022YFF0706500;National Natural Science Foundation of China,Grant/Award Numbers:22077093,32322046;Collaborative Innovation Center of Suzhou Nano Science and Technology;111 Program from the Ministry of Education of China;Suzhou Key Laboratory of Nanotechnology and Biomedicine;Natural Science Foundation of Jiangsu Province,Grant/Award Number:BK20220110。
Advanced drug delivery systems are widely considered to be powerful approaches for treating cancer and many other diseases because of their superior ability to improve pharmacokinetics,promote lesion-targeted delivery...
supported by the National Key Research and Development Project(No.2021YFA1201404);Major Project of the National Natural Science Foundation of China(Nos.81991514,82272530);Jiangsu Province Medical Innovation Center of Orthopedic Surgery(No.CXZX202214);Jiangsu Provincial Key Medical Center Foundation,Jiangsu Provincial Medical Outstanding Talent Foundation,Jiangsu Provincial Medical Youth Talent Foundation,Jiangsu Provincial Key Medical Talent Foundation;the Fundamental Research Funds for the Central Universities(Nos.14380493 and 14380494).
Osteoporosis is a metabolic dysregulation of bone that occurs mainly in postmenopausal women,and the hyperfunction of osteoclasts is the primary contributor to postmenopausal osteoporosis.However,the development of ef...
supported by the Natural Science Foundation of Guangdong Province (No.2023A1515030291);Science and Technology Program of Guangzhou (No.202201011130280065);National Natural Science Foundation of China (No.82172079);Special Fund of Foshan Climbing Peak Plan (No.2020B018)。
Despite the synergy of immune checkpoint blockade(ICB) therapy and photodynamic therapy(PDT) holds great promise as countermeasures against breast cancer, exploring long-term or flexible short-time therapeutic strateg...
supported by the National Key Research and Development Program of China(2021YFC2400600,2021YFE0103100);NFSC(81925035);Department of Science and Technology of Guangdong Province(High-level new R&D institute 2019B090904008,High-level Innovative Research Institute 2021B0909050003);the Scientific and Technological Innovation Leading Talent Project in Zhongshan City(LJ2021001);the Scientific Research and Innovation Team Project in Zhongshan City(CXTD2022011);and Research Foundation of Binzhou Medical University(BY2019KJ03).
Osimertinib (Osi) is widely used as a first-line treatment for non-small cell lung cancer (NSCLC) with EGFR mutations. However, the majority of patients treated with Osi eventually relapse within a year. The mechanism...
SKM gratefully acknowledges the support of Indian Council of Medical Research(ICMR),New Delhi,India(File No:6/9-7(308)/2023-ECD-II);RH acknowledges the SVMCM fellowship,West Bengal.
Visceral leishmaniasis(VL)is a neglected tropical disease,and this review has summarized the current treatment scenario and its prospects.It also highlights alternative approaches used by research groups in India and ...
Amultifunctional liposomal polydopamine nanoparticle(MPM@Lipo)was designed in this study,to combine chemotherapy,photothermal therapy(PTT)and oxygen enrichment to clear hyperproliferating inflammatory cells and improv...
supported by the National Science Fund for Distinguished Young Scholars(Overseas).
Immune checkpoint blockade(ICB)therapy for cancer has achieved great success both in clinical results and on the market.At the same time,success drives more attention from scientists to improve it.However,only a small...